The global market for Inactivated Poultry Vaccine was valued at US$ 3335 million in the year 2024 and is projected to reach a revised size of US$ 4519 million by 2031, growing at a CAGR of 4.5% during the forecast period.
Inactivated poultry vaccines belong to a class of preventative biologics called "subunit/inactivated virus vaccines." They contain only parts of the virus rather than the entire pathogen. These components are isolated from disease cells and weakened or killed before use in humans and animals so they won"t cause illness but still trigger immune responses to protect against subsequent exposure to live viruses.
The global inactivated poultry vaccine market represents one segment within the broader animal vaccines industry that includes subcategories based on species and diseases targeted. This particular subset serves as a critical component in global efforts to manage avian influenza outbreaks caused by deadly H5N8 and H5N6 strains spreading rapidly across continents posing serious threats to human and animal health. To combat this devastating threat, governments around the globe encourage research & development (R&D) investment in effective vaccines adaptable to different regions and birds breeds while companies strive to meet escalating consumer needs driving accelerated evolution towards safer, stronger formulations guaranteeing enhanced protection versus emerging virulent strains. Ongoing studies explore advanced manufacturing techniques and adjuvants promising increased potency and longevity, expanding opportunities for market expansion beyond current offerings leveraged mainly in Asian-Pacific countries where demand remains consistently strong. Suppliers maintain competitive edge via continuous innovation refining production processes ensuring quality performance under diverse conditions extending lifespans maximizing efficiency minimizing waste amidst persistent supply chain complexities faced daily by every participant operating within volatile environments rife with unpredictability testing resilience throughout extended value chains impacting everyone along each step necessitating flexibility adaptability sustaining viability securing future success.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Inactivated Poultry Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inactivated Poultry Vaccine.
The Inactivated Poultry Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inactivated Poultry Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inactivated Poultry Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Zoetis
Merck Animal Health
Boehringer Ingelheim
Elanco Animal Health
Phibro Animal Health
Virbac
Hipra
Venkys
Biovet
Ringpu Biology
Ceva Corporate
KM Biologics
Vaxxinova
Japfa Comfeed Indonesia
Nisseiken
Segment by Type
Liquid Vaccines
Freeze-Dried Vaccines
Segment by Application
Avian Encephalomyelitis
Chicken Anaemia
Egg Drop Syndrome
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inactivated Poultry Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inactivated Poultry Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Inactivated Poultry Vaccine Market Overview
1.1 Product Definition
1.2 Inactivated Poultry Vaccine by Type
1.2.1 Global Inactivated Poultry Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Liquid Vaccines
1.2.3 Freeze-Dried Vaccines
1.3 Inactivated Poultry Vaccine by Application
1.3.1 Global Inactivated Poultry Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Avian Encephalomyelitis
1.3.3 Chicken Anaemia
1.3.4 Egg Drop Syndrome
1.3.5 Others
1.4 Global Inactivated Poultry Vaccine Market Size Estimates and Forecasts
1.4.1 Global Inactivated Poultry Vaccine Revenue 2020-2031
1.4.2 Global Inactivated Poultry Vaccine Sales 2020-2031
1.4.3 Global Inactivated Poultry Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Inactivated Poultry Vaccine Market Competition by Manufacturers
2.1 Global Inactivated Poultry Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Inactivated Poultry Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Inactivated Poultry Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Inactivated Poultry Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Inactivated Poultry Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inactivated Poultry Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Inactivated Poultry Vaccine, Date of Enter into This Industry
2.8 Global Inactivated Poultry Vaccine Market Competitive Situation and Trends
2.8.1 Global Inactivated Poultry Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Inactivated Poultry Vaccine Players Market Share by Revenue
2.8.3 Global Inactivated Poultry Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Inactivated Poultry Vaccine Market Scenario by Region
3.1 Global Inactivated Poultry Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Inactivated Poultry Vaccine Sales by Region: 2020-2031
3.2.1 Global Inactivated Poultry Vaccine Sales by Region: 2020-2025
3.2.2 Global Inactivated Poultry Vaccine Sales by Region: 2026-2031
3.3 Global Inactivated Poultry Vaccine Revenue by Region: 2020-2031
3.3.1 Global Inactivated Poultry Vaccine Revenue by Region: 2020-2025
3.3.2 Global Inactivated Poultry Vaccine Revenue by Region: 2026-2031
3.4 North America Inactivated Poultry Vaccine Market Facts & Figures by Country
3.4.1 North America Inactivated Poultry Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Inactivated Poultry Vaccine Sales by Country (2020-2031)
3.4.3 North America Inactivated Poultry Vaccine Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Inactivated Poultry Vaccine Market Facts & Figures by Country
3.5.1 Europe Inactivated Poultry Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Inactivated Poultry Vaccine Sales by Country (2020-2031)
3.5.3 Europe Inactivated Poultry Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inactivated Poultry Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Inactivated Poultry Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Inactivated Poultry Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Inactivated Poultry Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Inactivated Poultry Vaccine Market Facts & Figures by Country
3.7.1 Latin America Inactivated Poultry Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Inactivated Poultry Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Inactivated Poultry Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inactivated Poultry Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Inactivated Poultry Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Inactivated Poultry Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Inactivated Poultry Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Inactivated Poultry Vaccine Sales by Type (2020-2031)
4.1.1 Global Inactivated Poultry Vaccine Sales by Type (2020-2025)
4.1.2 Global Inactivated Poultry Vaccine Sales by Type (2026-2031)
4.1.3 Global Inactivated Poultry Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Inactivated Poultry Vaccine Revenue by Type (2020-2031)
4.2.1 Global Inactivated Poultry Vaccine Revenue by Type (2020-2025)
4.2.2 Global Inactivated Poultry Vaccine Revenue by Type (2026-2031)
4.2.3 Global Inactivated Poultry Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Inactivated Poultry Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Inactivated Poultry Vaccine Sales by Application (2020-2031)
5.1.1 Global Inactivated Poultry Vaccine Sales by Application (2020-2025)
5.1.2 Global Inactivated Poultry Vaccine Sales by Application (2026-2031)
5.1.3 Global Inactivated Poultry Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Inactivated Poultry Vaccine Revenue by Application (2020-2031)
5.2.1 Global Inactivated Poultry Vaccine Revenue by Application (2020-2025)
5.2.2 Global Inactivated Poultry Vaccine Revenue by Application (2026-2031)
5.2.3 Global Inactivated Poultry Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Inactivated Poultry Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Company Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Zoetis Inactivated Poultry Vaccine Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Merck Animal Health
6.2.1 Merck Animal Health Company Information
6.2.2 Merck Animal Health Description and Business Overview
6.2.3 Merck Animal Health Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck Animal Health Inactivated Poultry Vaccine Product Portfolio
6.2.5 Merck Animal Health Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Company Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Boehringer Ingelheim Inactivated Poultry Vaccine Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Elanco Animal Health
6.4.1 Elanco Animal Health Company Information
6.4.2 Elanco Animal Health Description and Business Overview
6.4.3 Elanco Animal Health Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Elanco Animal Health Inactivated Poultry Vaccine Product Portfolio
6.4.5 Elanco Animal Health Recent Developments/Updates
6.5 Phibro Animal Health
6.5.1 Phibro Animal Health Company Information
6.5.2 Phibro Animal Health Description and Business Overview
6.5.3 Phibro Animal Health Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Phibro Animal Health Inactivated Poultry Vaccine Product Portfolio
6.5.5 Phibro Animal Health Recent Developments/Updates
6.6 Virbac
6.6.1 Virbac Company Information
6.6.2 Virbac Description and Business Overview
6.6.3 Virbac Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Virbac Inactivated Poultry Vaccine Product Portfolio
6.6.5 Virbac Recent Developments/Updates
6.7 Hipra
6.7.1 Hipra Company Information
6.7.2 Hipra Description and Business Overview
6.7.3 Hipra Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hipra Inactivated Poultry Vaccine Product Portfolio
6.7.5 Hipra Recent Developments/Updates
6.8 Venkys
6.8.1 Venkys Company Information
6.8.2 Venkys Description and Business Overview
6.8.3 Venkys Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Venkys Inactivated Poultry Vaccine Product Portfolio
6.8.5 Venkys Recent Developments/Updates
6.9 Biovet
6.9.1 Biovet Company Information
6.9.2 Biovet Description and Business Overview
6.9.3 Biovet Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Biovet Inactivated Poultry Vaccine Product Portfolio
6.9.5 Biovet Recent Developments/Updates
6.10 Ringpu Biology
6.10.1 Ringpu Biology Company Information
6.10.2 Ringpu Biology Description and Business Overview
6.10.3 Ringpu Biology Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Ringpu Biology Inactivated Poultry Vaccine Product Portfolio
6.10.5 Ringpu Biology Recent Developments/Updates
6.11 Ceva Corporate
6.11.1 Ceva Corporate Company Information
6.11.2 Ceva Corporate Description and Business Overview
6.11.3 Ceva Corporate Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Ceva Corporate Inactivated Poultry Vaccine Product Portfolio
6.11.5 Ceva Corporate Recent Developments/Updates
6.12 KM Biologics
6.12.1 KM Biologics Company Information
6.12.2 KM Biologics Description and Business Overview
6.12.3 KM Biologics Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 KM Biologics Inactivated Poultry Vaccine Product Portfolio
6.12.5 KM Biologics Recent Developments/Updates
6.13 Vaxxinova
6.13.1 Vaxxinova Company Information
6.13.2 Vaxxinova Description and Business Overview
6.13.3 Vaxxinova Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Vaxxinova Inactivated Poultry Vaccine Product Portfolio
6.13.5 Vaxxinova Recent Developments/Updates
6.14 Japfa Comfeed Indonesia
6.14.1 Japfa Comfeed Indonesia Company Information
6.14.2 Japfa Comfeed Indonesia Description and Business Overview
6.14.3 Japfa Comfeed Indonesia Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Japfa Comfeed Indonesia Inactivated Poultry Vaccine Product Portfolio
6.14.5 Japfa Comfeed Indonesia Recent Developments/Updates
6.15 Nisseiken
6.15.1 Nisseiken Company Information
6.15.2 Nisseiken Description and Business Overview
6.15.3 Nisseiken Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Nisseiken Inactivated Poultry Vaccine Product Portfolio
6.15.5 Nisseiken Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inactivated Poultry Vaccine Industry Chain Analysis
7.2 Inactivated Poultry Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inactivated Poultry Vaccine Production Mode & Process Analysis
7.4 Inactivated Poultry Vaccine Sales and Marketing
7.4.1 Inactivated Poultry Vaccine Sales Channels
7.4.2 Inactivated Poultry Vaccine Distributors
7.5 Inactivated Poultry Vaccine Customer Analysis
8 Inactivated Poultry Vaccine Market Dynamics
8.1 Inactivated Poultry Vaccine Industry Trends
8.2 Inactivated Poultry Vaccine Market Drivers
8.3 Inactivated Poultry Vaccine Market Challenges
8.4 Inactivated Poultry Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Zoetis
Merck Animal Health
Boehringer Ingelheim
Elanco Animal Health
Phibro Animal Health
Virbac
Hipra
Venkys
Biovet
Ringpu Biology
Ceva Corporate
KM Biologics
Vaxxinova
Japfa Comfeed Indonesia
Nisseiken
听
听
*If Applicable.